Consumer Genetic Test Win F.D.A. Approval
For the first time, food and drug administration allow a company to sell genetic test for disease risk directly to consumers, providing people with information about the likelihood that they could develop various condition, including Parkinson and Alzheimer. The company call 23andme, which is based in California, will be opening the road map for other companies to do the same. 23andme will now be reporting telltale markers for 10 diseases. Most, like factor XI deficiency, a blood clotting disorder, and Gaucher disease type 1, and organ and tissue illness, and celiac disease, which are rare. Anyone who buys the $199 ancestry and health test from the company will automatically learn if they have mutation increasing their risk for those diseases. Until now only way people get genetic test was to go thought medical professional that order the test and would required seeing a genetic counselor before getting the test. 23andme only been authorized to consumer in Britain and Canada, which have more lenient regulation in 2014 over 20,000 Britain customer got their genetic result with know known risk.